Comment on "Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma".

Suppr

超能文献

作者信息

Manjili Masoud H, Kmieciak Maciej, Keeler Johanna

出版信息

J Immunol. 2006 Apr 15;176(8):4511; author reply 4511-2. doi: 10.4049/jimmunol.176.8.4511.

DOI:10.4049/jimmunol.176.8.4511

PMID:16585536

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1458368/

Abstract

摘要

相似文献

Comment on "Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma".

J Immunol. 2006 Apr 15;176(8):4511; author reply 4511-2. doi: 10.4049/jimmunol.176.8.4511.

Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma.

J Immunol. 2005 Nov 1;175(9):6169-76. doi: 10.4049/jimmunol.175.9.6169.

Naturally occurring human lymphocyte antigen-A2 restricted CD8+ T-cell response to the cancer testis antigen NY-ESO-1 in melanoma patients.

Cancer Res. 2000 Aug 15;60(16):4499-506.

Lack of terminally differentiated tumor-specific CD8+ T cells at tumor site in spite of antitumor immunity to self-antigens in human metastatic melanoma.

Cancer Res. 2003 May 15;63(10):2535-45.

The immune response to melanoma is limited by thymic selection of self-antigens.

PLoS One. 2012;7(4):e35005. doi: 10.1371/journal.pone.0035005. Epub 2012 Apr 10.

In vivo activation of melanoma-specific CD8(+) T cells by endogenous tumor antigen and peptide vaccines. A comparison to virus-specific T cells.

Eur J Immunol. 2002 Mar;32(3):731-41. doi: 10.1002/1521-4141(200203)32:3<731::AID-IMMU731>3.0.CO;2-H.

Neoantigen-reactive CD8+ T cells affect clinical outcome of adoptive cell therapy with tumor-infiltrating lymphocytes in melanoma.

J Clin Invest. 2022 Jan 18;132(2). doi: 10.1172/JCI150535.

Melan-A/MART-1-specific CD8 T cells: from thymus to tumor.

Trends Immunol. 2002 Jul;23(7):325-8. doi: 10.1016/s1471-4906(02)02244-5.

Tumor progression despite massive influx of activated CD8(+) T cells in a patient with malignant melanoma ascites.

Cancer Immunol Immunother. 2006 Oct;55(10):1185-97. doi: 10.1007/s00262-005-0118-2. Epub 2006 Feb 9.

Single injection of CD34+ progenitor-derived dendritic cell vaccine can lead to induction of T-cell immunity in patients with stage IV melanoma.

J Immunother. 2003 Sep-Oct;26(5):432-9. doi: 10.1097/00002371-200309000-00006.

引用本文的文献

Adoptive transfer of tumor reactive B cells confers host T-cell immunity and tumor regression.

Clin Cancer Res. 2011 Aug 1;17(15):4987-95. doi: 10.1158/1078-0432.CCR-11-0207. Epub 2011 Jun 20.

In vivo sensitized and in vitro activated B cells mediate tumor regression in cancer adoptive immunotherapy.

J Immunol. 2009 Sep 1;183(5):3195-203. doi: 10.4049/jimmunol.0803773. Epub 2009 Aug 10.

HER-2/neu antigen loss and relapse of mammary carcinoma are actively induced by T cell-mediated anti-tumor immune responses.

Eur J Immunol. 2007 Mar;37(3):675-85. doi: 10.1002/eji.200636639.

本文引用的文献

Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma.

J Immunol. 2005 Nov 1;175(9):6169-76. doi: 10.4049/jimmunol.175.9.6169.

Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells.

J Exp Med. 2005 Oct 3;202(7):907-12. doi: 10.1084/jem.20050732.

Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma.

J Clin Oncol. 2005 Apr 1;23(10):2346-57. doi: 10.1200/JCO.2005.00.240.

Cancer immunotherapy: moving beyond current vaccines.

Nat Med. 2004 Sep;10(9):909-15. doi: 10.1038/nm1100.

Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells.

J Exp Med. 2003 Aug 18;198(4):569-80. doi: 10.1084/jem.20030590.

Natural selection of tumor variants in the generation of "tumor escape" phenotypes.

Nat Immunol. 2002 Nov;3(11):999-1005. doi: 10.1038/ni1102-999.

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes.

Science. 2002 Oct 25;298(5594):850-4. doi: 10.1126/science.1076514. Epub 2002 Sep 19.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验